-+ 0.00%
-+ 0.00%
-+ 0.00%

Indivior sets USD 8.13 special dividend tied to Supernus merger closing

PUBT·09/17/2026 11:01:13
Listen to the news
Indivior sets USD 8.13 special dividend tied to Supernus merger closing
  • Indivior Pharmaceuticals is pursuing a merger with Supernus, targeted to close on or about Nov. 2, 2026.
  • The deal triggers a contingent special cash dividend of $8.13 per Indivior share to holders of record on Oct. 30, 2026.
  • Dividend payment is expected on or about Nov. 6, 2026 if the merger closes; it will not be paid if the deal fails.
  • Supernus shareholders will not receive the dividend on any Indivior shares issued as merger consideration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170700PRIMZONEFULLFEED9828482) on September 17, 2026, and is solely responsible for the information contained therein.